Trivascular Secures $60,000,000 Series C Financing

  • Feed Type
  • Date
    7/13/2010
  • Company Name
    Trivascular
  • Mailing Address
    3910 Brickway Blvd Santa Rosa, CA 95403
  • Company Description
    Trivascular is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA).
  • Website
    http://www.trivascular2.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $60,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be used to launch the company’s OvationTM Abdominal Stent Graft System in Europe, drive clinical research activity across three continents, and fuel next generation product development.
  • M&A Terms
  • Venture Investor
    Pinnacle Ventures
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    MPM Capital
  • Venture Investor
    Kearny Venture Partners

By posting a comment, you agree to our terms and conditions.